PULSAR open-label extension: interim results from a phase 2 study of the efficacy and safety of sotatercept when added to standard of care for the treatment of pulmonary arterial hypertension (PAH)

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorBADESCH, David
dc.contributor.authorGIBBS, Simon
dc.contributor.authorGOMBERG-MAITLAND, Mardi
dc.contributor.authorHOEPER, Marius
dc.contributor.authorMCLAUGHLIN, Vallerie
dc.contributor.authorPRESTON, Ioana
dc.contributor.authorSOUZA, Rogerio
dc.contributor.authorWAXMAN, Aaron
dc.contributor.authorMANIMARAN, Solaiappan
dc.contributor.authorBARNES, Jennifer
dc.contributor.authorPENA, Janethe De Oliveira
dc.contributor.authorHUMBERT, Marc
dc.contributor.authorHOEPER, Marius M.
dc.date.accessioned2022-04-05T18:23:24Z
dc.date.available2022-04-05T18:23:24Z
dc.date.issued2021
dc.description.indexMEDLINEeng
dc.identifier.citationEUROPEAN RESPIRATORY JOURNAL, v.58, suppl.65, 2021
dc.identifier.doi10.1183/13993003.congress-2021.OA140
dc.identifier.eissn1399-3003
dc.identifier.issn0903-1936
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/45611
dc.language.isoeng
dc.publisherEUROPEAN RESPIRATORY SOC JOURNALS LTDeng
dc.relation.ispartofEuropean Respiratory Journal
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright EUROPEAN RESPIRATORY SOC JOURNALS LTDeng
dc.subjectPulmonary hypertensioneng
dc.subject.wosRespiratory Systemeng
dc.titlePULSAR open-label extension: interim results from a phase 2 study of the efficacy and safety of sotatercept when added to standard of care for the treatment of pulmonary arterial hypertension (PAH)eng
dc.typeconferenceObjecteng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryAlemanha
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisode
hcfmusp.affiliation.countryisofr
hcfmusp.author.externalBADESCH, David:Univ Colorado, Aurora, CO USA
hcfmusp.author.externalGIBBS, Simon:Imperial Coll London, Natl Heart & Lung Inst, London, England
hcfmusp.author.externalGOMBERG-MAITLAND, Mardi:George Washington Univ, Washington, DC USA
hcfmusp.author.externalHOEPER, Marius:Hannover Med Sch, Dept Resp Med, Hannover, Germany; German Ctr Lung Res, Hannover, Germany; Univ Paris Saclay, Hannover, Germany
hcfmusp.author.externalMCLAUGHLIN, Vallerie:Univ Michigan, Ann Arbor, MI 48109 USA
hcfmusp.author.externalPRESTON, Ioana:Tufts Med Ctr, Boston, MA 02111 USA
hcfmusp.author.externalWAXMAN, Aaron:Brigham & Womens Hosp, Boston, MA USA
hcfmusp.author.externalMANIMARAN, Solaiappan:Acceleron Pharma, Cambridge, England
hcfmusp.author.externalBARNES, Jennifer:Acceleron Pharma, Cambridge, England
hcfmusp.author.externalPENA, Janethe De Oliveira:Acceleron Pharma, Cambridge, England
hcfmusp.author.externalHUMBERT, Marc:Univ Paris Saclay, Assistance Publ Hop Paris, Le Kremlin Bicetre, France
hcfmusp.author.externalHOEPER, Marius M.:Univ Paris Saclay, Hannover, Germany
hcfmusp.contributor.author-fmusphcROGERIO DE SOUZA
hcfmusp.description.issuesuppl 65
hcfmusp.description.volume58
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000747452100122
hcfmusp.publisher.citySHEFFIELDeng
hcfmusp.publisher.countryENGLANDeng
relation.isAuthorOfPublication502d5aeb-c5a4-4275-8c07-02d25223d6d1
relation.isAuthorOfPublication.latestForDiscovery502d5aeb-c5a4-4275-8c07-02d25223d6d1
Arquivos